Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East, and Africa; and Asia Pacific segments. It offers integrated facilities management, project and development, portfolio administration, transaction management, and strategic consulting services; property management services, including client accounting, engineering and operations, lease compliance administration, project and development, and sustainability services; and self-performed facilities services, which include janitorial, maintenance, critical environment management, landscaping, and office services. The company also provides owner representation and tenant representation leasing services; capital market services, such as investment sales and equity, and debt and structured financing for real estate purchase and sales transactions; and appraisal management, investment management, valuation advisory, portfolio advisory, diligence advisory, dispute analysis and litigation support, financial reporting, and property and/or portfolio valuation services on real estate debt and equity decisions. Cushman & Wakefield has a strategic partnership with Vanke Service. It serves real estate owners and occupiers, such as tenants, investors, and multi-national corporations. Cushman & Wakefield plc was founded in 1784 and is headquartered in Chicago, Illinois.
IPO Year: 2018
Exchange: NYSE
Website: cushmanwakefield.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/2/2025 | $18.00 → $14.00 | Buy → Hold | Jefferies |
12/6/2024 | $15.00 | Sell | Goldman |
4/10/2024 | $13.00 | Buy | Jefferies |
4/9/2024 | Outperform → Peer Perform | Wolfe Research | |
4/3/2024 | $13.00 | Strong Buy → Outperform | Raymond James |
12/8/2023 | $12.00 | Peer Perform → Outperform | Wolfe Research |
4/17/2023 | $19.00 → $10.00 | Buy → Neutral | UBS |
4/10/2023 | $15.50 → $11.00 | Buy → Neutral | Goldman |
2/1/2023 | Outperform → Peer Perform | Wolfe Research | |
4/5/2022 | $25.00 | Buy | Goldman |